AbbVie Long-Term Investments 2012-2026 | ABBV

AbbVie long-term investments for the quarter ending March 31, 2026 were $291M, a 8.99% increase year-over-year.

  • AbbVie long-term investments for 2024 were $0.279B, a 8.22% decline from 2023.
  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.

AbbVie Long-Term Investments 2012-2026 | ABBV

  • AbbVie long-term investments for 2024 were $0.279B, a 8.22% decline from 2023.
  • AbbVie long-term investments for 2023 were $0.304B, a 26.14% increase from 2022.
  • AbbVie long-term investments for 2022 were $0.241B, a 13% decline from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$887.6B
Johnson & Johnson (JNJ)$574.4B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B